Mirena Observational Program

Bayer2,725 enrolled

Overview

Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy

Study Type

OBSERVATIONAL

Enrollment

2,725

Conditions

Contraception Menorrhagia Endometrial Hyperplasia Estrogen Replacement Therapy

Interventions

Levonorgestrel (Mirena, BAY86-5028)DRUG

Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications Exclusion Criteria: * All patients with contraindications to Mirena insertion, according to approved prescribing information.

Locations (1)

Unnamed facility

Many Locations, Kazakhstan

Outcomes

Primary Outcomes

Patient distribution per indication

Time frame: 12 months

Secondary Outcomes

Patient compliance

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.